Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 10:46 PM
Study NCT ID:
NCT01321567
Status:
COMPLETED
Last Update Posted:
2023-07-24
First Post:
2011-03-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis
Sponsor:
Eisai Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2013-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-18
First Submit QC Date:
None
Study First Post Date:
2011-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-21
Last Update Post Date:
2023-07-24
Last Update Post Date Type:
ACTUAL